Table 3 Over- or underexpression of complement genes as defined by ≥50% of CFS subjects who showed ≥ two-fold expression changes in response to an exercise challenge compared with the median of the control group. a
From: Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome
| Â | Normalization method | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | PPIB b | GM | rbcL | ||||||
Gene | T0 | T1 | T2 | T0 | T1 | T2 | T0 | T1 | T2 |
C1QA | — | 62.50 | 57.14 | — | — | — | 50.00 | — | — |
C1S | — | — | — | — | 62.50 | — | — | — | — |
C4 | — | 75.00 | — | — | 62.50 | — | — | 62.50 | — |
MASP2 | 62.50 | 62.50 | 57.14 | — | 50.00 | — | 50.00 | 62.50 | — |
FCN1 | — | 62.50 | — | — | 50.00 | — | — | 62.50 | — |
FCN2 | 50.00 | 50.00 | — | — | — | — | — | — | — |
SERPING1 | — | — | — | 50.00 | — | — | — | — | — |
IFN-γ | 62.50 | — | — | 50.00 | 50.00 | 57.14 | — | — | — |